Global Cytomegalovirus (CMV) Vaccine Market by Type (Attenuated Vaccines, Subunit Vaccines), By Application (Laboratories, Hospitals, Diagnostic Centers and Clinics, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global cytomegalovirus (CMV) vaccine market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The CMV vaccine market is segmented on the basis of type, application and region. On the basis of type, the CMV vaccine market is segmented into attenuated vaccines and subunit vaccines. Attenuated vaccines are further sub-segmented into live attenuated virus (LAIV) and inactivated virus (IV). On the basis of application, laboratories, hospitals, diagnostic centers and clinics are included in this study.



Get Free Sample Report

Product Definition:

Cytomegalovirus (CMV) Vaccine is a vaccine that helps protect against cytomegalovirus (CMV), a virus that can cause serious illness in people with weakened immune systems. Cytomegalovirus (CMV) Vaccine is important because it can help prevent serious illness in people who are at risk for getting sick from cytomegalovirus (CMV).

Attenuated Vaccines:

Attenuated vaccines are those that involve the use of weakened or dead virus particles. These viruses can cause infection in humans and animals when they are transmitted through contaminated hands, food, water or air.

The most common way to produce an attenuated vaccine is by using a cold-chain system; this involves keeping the vaccine at a specific temperature (2-8 degrees) for increasing duration to reduce the viability of virus particles.

Subunit Vaccines:

Subunit vaccines are a type of vaccine that contains only the active ingredient(s) in the form of a solution or suspension. The other ingredients present may be stabilizers, preservatives, inert materials such as sucrose or phosphate buffer, etc. These ingredients do not stimulate an immune response and hence there is no need to refrigerate these vaccines before using them.

The most commonly used subunit vaccine is M-M-R II (Merck & Co., Inc.

Application Insights:

Laboratories accounted for the largest share of over 60.0% in 2017 owing to the extensive usage of cytomegalovirus (CMV) vaccines in research activities. The use of CMV-based vaccines has enabled researchers to study pathogenesis and develop efficient therapeutic strategies against this disease, which is anticipated to boost segment growth during the forecast period.

The hospitals segment is expected to witness a lucrative CAGR over the forecast period due to increasing prevalence of chronic diseases, such as cancer and diabetes mellitus, which are associated with immunodeficiency disorders. This trend is likely drive demand for CMV vaccine within this application segment during future years. In addition, an increase in healthcare spending across various regions has further propelled market growth since 2014; however, economic slowdown witnessed across several countries may hinder demand from 2018 onward depending upon regional differences.

Regional Analysis:

North America dominated the global market in 2017. The presence of a strong research base and higher awareness levels pertaining to CMV infection are some of the major factors responsible for its large share. In addition, increasing incidence of cancer is also expected to boost demand for cytomegalovirus vaccines in this region over the forecast period.

Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to rising target population along with growing healthcare spending by countries like China and India. Moreover, favorable government initiatives coupled with increasing R&D investment by pharmaceutical companies will further propel revenue growth in this region during the forecast period from 2018 to 2030  (USD X). For instance, Novo Nordisk has been supporting immunization programs through donations & grants as well as through its support for CMV-TIV program initiated by Merck & Co., Inc.

Growth Factors:

Increasing incidence of CMV infections: The increasing incidence of CMV infections is one of the major growth drivers for the Cytomegalovirus (CMV) Vaccine market. CMV is a common virus that can cause serious health problems in people with weakened immune systems, such as cancer patients and organ transplant recipients. According to a study by the Centers for Disease Control and Prevention (CDC), an estimated 1 in 150 Americans are infected with CMV, and around 5,000 newborns develop congenital CMV infection each year in the U.S.
Growing demand for preventive vaccines: The growing demand for preventive vaccines is another major growth driver for the Cytomegalovirus (CMV) Vaccine market. With increasing awareness about the benefits of vaccination, more people are opting for preventive vaccinations against various diseases including CMV infection.
Technological advancements in vaccine development: The technological advancements in vaccine development are also driving the growth of the Cytomegalovirus (CM) Vaccine market . In recent years, there has been significant progress made in developing new and innovative vaccines against various diseases including cytomegalovirus infection . This is likely to boost demand for cytomegalovirus vaccines over next few years .


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Cytomegalovirus (CMV) Vaccine Market Research Report
By Type
Attenuated Vaccines, Subunit Vaccines
By Application
Laboratories, Hospitals, Diagnostic Centers and Clinics, Others
By Companies
Merck, AlphaVax, Moderna, Novartis, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.

Global Cytomegalovirus (CMV) Vaccine Market Report Segments:
The global Cytomegalovirus (CMV) Vaccine market is segmented on the basis of:
Types
Attenuated Vaccines, Subunit Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratories, Hospitals, Diagnostic Centers and Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
Merck
AlphaVax
Moderna
Novartis
Merck



Get Free Sample Report

Highlights of The Cytomegalovirus (CMV) Vaccine Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
Attenuated Vaccines
Subunit Vaccines
By Application:
Laboratories
Hospitals
Diagnostic Centers and Clinics
Others
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cytomegalovirus (CMV) Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?